Mind the gap: Time to address implementation gaps in tuberculosis diagnosis and treatment

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Volumn 6, Issue , 2017, Pages 14-15

  Pai, Madhukar ^a   Temesgen, Zelalem ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85011884890     PISSN: None     EISSN: 24055794     Source Type: Journal    
DOI: 10.1016/j.jctube.2016.02.001     Document Type: Editorial

References (12)

1. [1] World Health Organization. Global tuberculosis report 2015. 2015, WHO, Geneva.
2. [2] Udwadia, Z.F., MDR, XDR, TDR tuberculosis: ominous progression. Thorax 67:4 (2012), 286–288.
3. [3] Pai, M., Daftary, A., Satyanarayana, S., Tuberculosis control: challenges and opportunities for India. Trans Roy Soc Trop Med Hyg 110:3 (2016), 158–160.
4. [4] Gilliam, B.L., Patel, D., Talwani, R., Temesgen, Z., HIV in Africa: challenges and directions for the next decade. Curr Infect Dis Rep 14:1 (2012), 91–101.
5. [5] Steingart, K., Schiller, I., Horne, D.J., Pai, M., Boehme, C., Dendukuri, N., Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev, 1, 2014 Jan 21, CD009593.
6. [6] Sachdeva, K.S., Raizada, N., Sreenivas, A., Van't Hoog, A.H., van den Hof, S., Dewan, P.K., et al. Use of Xpert MTB/RIF in decentralized public health settings and its effect on pulmonary TB and DR-TB case finding in India. PLoS One, 10(5), 2015 May 21, e0126065.
7. [7] Medicins Sans Frontiers and Stop TB Partnership. Out of Step 2015. TB policies in 24 countries. URL: http://www.stoptb.org/assets/documents/news/report_out_of_step_2015_11_pdf_with_interactive_links.pdf2015. (accessed).
8. [8] Jacobson, K.R., Theron, D., Kendall, E.A., Franke, M.F., Barnard, M., van Helden, P.D., et al. Implementation of GenoType(R) MTBDRplus reduces time to multidrug-resistant tuberculosis therapy initiation in South Africa. Clin Infect Dis 56:4 (Feb 2012), 503–508.
9. [9] Theron, G., Zijenah, L., Chanda, D., Clowes, P., Rachow, A., Lesosky, M, et al. Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial. Lancet 383 (2013), 424–435.
10. [10] Sreeramareddy, C.T., Qin, Z.Z., Satyanarayana, S., Subbaraman, R., Pai, M., Delays in diagnosis and treatment of pulmonary tuberculosis in India: a systematic review. Int J Tuberc Lung Dis 18:3 (2014), 255–266.
11. [11] Satyanarayana, S., Subbaraman, R., Shete, P., Gore, G., Das, J., Cattamanchi, A., et al. Quality of tuberculosis care in India: a systematic review. Int J Tuberc Lung Dis 19:7 (2015), 751–763.
12. [12] Das, J., Kwan, A., Daniels, B., Satyanarayana, S., Subbaraman, R., Bergkvist, S, et al. Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study. Lancet Infect Dis 15:11 (2015), 1305–1313.